(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AQNEURSA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

AQNEURSA

ST13

US500000098104776

Class

5

Filing

98104776

Registration

7707978

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

18

Latest update

05/01/2025

Trademark type

Word

Nice classes

5

Filing date

07/27/2023

Registration date

02/25/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/25/2025

Last transaction

05/01/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/25/2024

First use in commerce

09/25/2024

Drawing code

4

Owner type

03

Owner location

AUSTIN, TX

Examiner

MARTIN, CHRISTINE

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

INTRABIO INC.
IntraBio Ltd

Representatives

Monica Riva Talley STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparations for activating cellular function; pharmaceutical preparations for the prevention and treatment of diseasesdisordersconditions of the nervous system; pharmaceutical preparations for treating sensory organ disorders; pharmaceutical preparations for treating nervous system injury or impairment; pharmaceutical preparations for use in the prevention and treatment of neurological and neurodegenerative diseases; drugs for medical purposesdrugs for the prevention and treatment of neurological and neurodegenerative diseases

Publications

History of USPTO decisions and trademark events.

18 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

04/30/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/25/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/25/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

02/04/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/04/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/30/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/30/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/07/2024

IUAF

USE AMENDMENT FILED

09/26/2024

EISU

TEAS STATEMENT OF USE RECEIVED

09/26/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/02/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/07/2024

PUBO

PUBLISHED FOR OPPOSITION

05/07/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/17/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/29/2024

DOCK

ASSIGNED TO EXAMINER

03/28/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/27/2023

NWAP

NEW APPLICATION ENTERED

07/31/2023

Continuous trademark protection

Get notified about every new filing that threatens AQNEURSA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.